1.	Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Phase: Phase III Type: Supportive care Status: Completed Age: 12 and over Sponsor: NCI, Other Protocol IDs: 1603.00, FHCRC-1603.00, NCI-H02-0092, CDR0000256871, NCT00045292
2.	Phase I Study of Genetically Modified CD8+ HIV-Specific T Cells for HIV-Seropositive Patients Undergoing Allogeneic Bone Marrow or Syngeneic T-Cell-Depleted PBSC Transplantation (Summary Last Modified 06/95) Phase: Phase I Type: Treatment Status: Closed Age: 18 to 45 Sponsor: NCI Protocol IDs: FHCRC-696.2, NCI-H94-0411
3.	Phase I Pilot Study of ZDV in HIV-Seropositive Patients Undergoing Allogeneic Bone Marrow Transplantation for non-Hodgkin's Lymphoma (Summary Last Modified 03/95) Phase: Phase I Type: Treatment Status: Closed Age: 12 and over Sponsor: Protocol IDs: FHCRC-526.0, NCI-V94-0412
4.	Acyclovir for Epstein-Barr Virus-Associated Chronic Lymphocytic Leukemia Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCI-82-C-59